Source: Current Medicinal Chemistry, Volume 12, Number 26, December 2005 , pp. 3163-3163(1)
Publisher: Bentham Science Publishers
Abstract:Due to an overlook on the part of the authors in Current Medicinal Chemistry, 2005, 12(7), 877-85 of article "2(3H)- Benzoxazolone and Bioisosters as 'Privileged Scaffold' in the Design of Pharmacological Probes" by Jacques Poupaert, Pascal Carato, Evelina Colacino and Saïd Yous. Two mistakes were unfortunately encountered: The affiliation of Dr Pascal Carato was not mentioned and the authorship of Prof. Saïd Yous had been lost.
The list of authors should therefore read:
Jacques H. Poupaerta, Pascal Caratob, Evelina Colcinoa and Saïd Yousb. and the affiliations should read as following:
aUnite de Chimie Pharmaceutique et Radiopharmacie, Ecole de Pharmacie, Universite Catholique de Louvain, (UCL-CMFA 7340), Brussels B-1200, Belgium. firstname.lastname@example.org bLaboratoire de Chimie Thérapeutique, EA 1043, Faculté des Sciences Pharmaceutiques et Biologiques de Lille, 3, rue du, Professeur Laguesse, BP 83, 59006 LILLE Cedex FRANCE
Document Type: Addendum
Publication date: December 1, 2005
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.